Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histiocytosis, Langerhans-Cell | 13 | 2024 | 224 | 3.600 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 7 | 2024 | 145 | 1.100 |
Why?
|
| Xanthogranuloma, Juvenile | 2 | 2022 | 31 | 0.930 |
Why?
|
| Proto-Oncogene Proteins B-raf | 4 | 2024 | 167 | 0.790 |
Why?
|
| Histiocytosis, Sinus | 1 | 2022 | 31 | 0.790 |
Why?
|
| Benzimidazoles | 1 | 2022 | 132 | 0.730 |
Why?
|
| Histiocytosis | 1 | 2020 | 19 | 0.690 |
Why?
|
| Pneumothorax | 1 | 2020 | 77 | 0.640 |
Why?
|
| Hodgkin Disease | 2 | 2019 | 294 | 0.630 |
Why?
|
| Telomere Shortening | 1 | 2019 | 33 | 0.630 |
Why?
|
| Telomerase | 1 | 2019 | 160 | 0.600 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2019 | 125 | 0.580 |
Why?
|
| Rituximab | 1 | 2018 | 157 | 0.580 |
Why?
|
| Neutropenia | 1 | 2019 | 200 | 0.560 |
Why?
|
| Glioma | 1 | 2022 | 491 | 0.560 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 2016 | 5 | 0.530 |
Why?
|
| Mutation | 4 | 2019 | 5825 | 0.530 |
Why?
|
| Lung Diseases | 1 | 2020 | 383 | 0.530 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 808 | 0.490 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 375 | 0.470 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2016 | 136 | 0.460 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 1214 | 0.420 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2022 | 206 | 0.410 |
Why?
|
| Histiocytes | 2 | 2022 | 23 | 0.340 |
Why?
|
| Adolescent | 16 | 2024 | 19287 | 0.330 |
Why?
|
| Infant | 13 | 2024 | 12475 | 0.330 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2024 | 529 | 0.330 |
Why?
|
| Child, Preschool | 13 | 2024 | 14018 | 0.320 |
Why?
|
| Child | 17 | 2024 | 24386 | 0.310 |
Why?
|
| Fever of Unknown Origin | 2 | 2018 | 45 | 0.300 |
Why?
|
| Humans | 31 | 2024 | 124728 | 0.260 |
Why?
|
| Signal Transduction | 2 | 2017 | 4493 | 0.230 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2004 | 2 | 0.230 |
Why?
|
| MAP Kinase Signaling System | 2 | 2024 | 310 | 0.230 |
Why?
|
| Remission Induction | 2 | 2023 | 299 | 0.230 |
Why?
|
| Arthritis, Juvenile | 1 | 2024 | 43 | 0.220 |
Why?
|
| Rheumatic Diseases | 1 | 2024 | 70 | 0.220 |
Why?
|
| Young Adult | 7 | 2024 | 9024 | 0.220 |
Why?
|
| Adult | 13 | 2024 | 29489 | 0.210 |
Why?
|
| Interferon-gamma | 2 | 2022 | 502 | 0.210 |
Why?
|
| Kidney Transplantation | 2 | 2018 | 643 | 0.210 |
Why?
|
| Cytarabine | 1 | 2023 | 98 | 0.200 |
Why?
|
| Meningioma | 1 | 2004 | 120 | 0.200 |
Why?
|
| Brain Neoplasms | 2 | 2018 | 1212 | 0.200 |
Why?
|
| Meningeal Neoplasms | 1 | 2004 | 185 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 85 | 0.190 |
Why?
|
| Antibodies, Monoclonal | 2 | 2024 | 1018 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 883 | 0.190 |
Why?
|
| Male | 18 | 2024 | 61270 | 0.190 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2020 | 325 | 0.180 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 158 | 0.180 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 618 | 0.180 |
Why?
|
| Pleurodesis | 1 | 2020 | 16 | 0.170 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 505 | 0.170 |
Why?
|
| Female | 17 | 2024 | 66570 | 0.170 |
Why?
|
| Chest Tubes | 1 | 2020 | 35 | 0.170 |
Why?
|
| Thiotepa | 1 | 2020 | 14 | 0.170 |
Why?
|
| Sepsis | 2 | 2021 | 478 | 0.170 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2021 | 225 | 0.170 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2020 | 99 | 0.160 |
Why?
|
| Blood Cells | 1 | 2019 | 49 | 0.160 |
Why?
|
| Etanercept | 1 | 2018 | 41 | 0.150 |
Why?
|
| Janus Kinases | 1 | 2018 | 31 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 394 | 0.150 |
Why?
|
| Graft Rejection | 2 | 2018 | 590 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 472 | 0.150 |
Why?
|
| STAT1 Transcription Factor | 1 | 2018 | 73 | 0.150 |
Why?
|
| Osteopontin | 1 | 2018 | 48 | 0.150 |
Why?
|
| Transplantation Conditioning | 1 | 2020 | 324 | 0.150 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 649 | 0.140 |
Why?
|
| Smad6 Protein | 1 | 2017 | 8 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2017 | 111 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 220 | 0.130 |
Why?
|
| Databases, Genetic | 1 | 2019 | 473 | 0.130 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2018 | 205 | 0.130 |
Why?
|
| Clonal Evolution | 1 | 2016 | 40 | 0.130 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 64 | 0.130 |
Why?
|
| Hydroxyurea | 1 | 2016 | 82 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 681 | 0.130 |
Why?
|
| Genetic Testing | 2 | 2021 | 1002 | 0.120 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 332 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 249 | 0.120 |
Why?
|
| Treatment Outcome | 8 | 2024 | 12357 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 2017 | 382 | 0.120 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2016 | 163 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2016 | 399 | 0.120 |
Why?
|
| Infant, Newborn | 4 | 2020 | 8191 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2020 | 1199 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 879 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 1659 | 0.110 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 1684 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3556 | 0.090 |
Why?
|
| Exome | 1 | 2016 | 1034 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 677 | 0.090 |
Why?
|
| Genome, Human | 1 | 2018 | 1273 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 2895 | 0.090 |
Why?
|
| Cardiac Output | 1 | 2011 | 170 | 0.090 |
Why?
|
| Biopsy | 3 | 2018 | 1237 | 0.090 |
Why?
|
| Recurrence | 2 | 2024 | 1421 | 0.090 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 1883 | 0.080 |
Why?
|
| Prognosis | 1 | 2019 | 4627 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 1701 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 369 | 0.080 |
Why?
|
| Mycophenolic Acid | 2 | 2018 | 51 | 0.080 |
Why?
|
| Oxygen | 1 | 2011 | 553 | 0.070 |
Why?
|
| Anemia | 1 | 2011 | 338 | 0.070 |
Why?
|
| Bone Marrow | 2 | 2018 | 324 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3154 | 0.070 |
Why?
|
| Still's Disease, Adult-Onset | 1 | 2024 | 3 | 0.060 |
Why?
|
| Paresis | 1 | 2004 | 35 | 0.060 |
Why?
|
| Adenine Nucleotides | 1 | 2024 | 41 | 0.060 |
Why?
|
| Arabinonucleosides | 1 | 2024 | 32 | 0.060 |
Why?
|
| Clone Cells | 1 | 2004 | 166 | 0.060 |
Why?
|
| Middle Aged | 3 | 2024 | 26797 | 0.050 |
Why?
|
| Spinal Neoplasms | 1 | 2004 | 58 | 0.050 |
Why?
|
| Epilepsies, Partial | 1 | 2004 | 91 | 0.050 |
Why?
|
| Salvage Therapy | 1 | 2024 | 192 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2004 | 290 | 0.050 |
Why?
|
| Renal Dialysis | 2 | 2018 | 852 | 0.050 |
Why?
|
| Exons | 1 | 2004 | 796 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 451 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 468 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2021 | 228 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2024 | 16335 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2021 | 172 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 191 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 176 | 0.040 |
Why?
|
| Antigens, CD1 | 1 | 2020 | 21 | 0.040 |
Why?
|
| Mannose-Binding Lectins | 1 | 2020 | 24 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2017 | 3284 | 0.040 |
Why?
|
| Biomarkers | 2 | 2020 | 3067 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 243 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2020 | 71 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2020 | 101 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2019 | 64 | 0.040 |
Why?
|
| Drug Eruptions | 1 | 2019 | 32 | 0.040 |
Why?
|
| Antigens, Fungal | 1 | 2018 | 34 | 0.040 |
Why?
|
| Histoplasma | 1 | 2018 | 30 | 0.040 |
Why?
|
| Liver Failure | 1 | 2019 | 89 | 0.040 |
Why?
|
| Histoplasmosis | 1 | 2018 | 47 | 0.040 |
Why?
|
| Amphotericin B | 1 | 2018 | 90 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2018 | 250 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 676 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 116 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2020 | 420 | 0.040 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 104 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 591 | 0.040 |
Why?
|
| Nitriles | 1 | 2018 | 146 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 778 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2020 | 367 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 270 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 139 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 293 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2020 | 409 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2017 | 87 | 0.030 |
Why?
|
| Pyrroles | 1 | 2018 | 177 | 0.030 |
Why?
|
| Viral Load | 1 | 2018 | 384 | 0.030 |
Why?
|
| Piperidines | 1 | 2018 | 204 | 0.030 |
Why?
|
| Cytomegalovirus Infections | 1 | 2018 | 219 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 183 | 0.030 |
Why?
|
| United States | 2 | 2024 | 10899 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2018 | 304 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 230 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 524 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2018 | 367 | 0.030 |
Why?
|
| Fetal Diseases | 1 | 2019 | 455 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 1090 | 0.030 |
Why?
|
| Family | 1 | 2017 | 563 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2018 | 397 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 873 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 536 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2018 | 750 | 0.030 |
Why?
|
| Aged | 2 | 2024 | 19764 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4375 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 3038 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 2047 | 0.020 |
Why?
|
| Lactates | 1 | 2011 | 93 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2011 | 186 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 4342 | 0.020 |
Why?
|
| Oximetry | 1 | 2011 | 162 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2011 | 304 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4255 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2011 | 309 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 4806 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2634 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3586 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2428 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 2982 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 1352 | 0.020 |
Why?
|
| Neoplasms | 1 | 2019 | 2788 | 0.010 |
Why?
|
| Mice | 1 | 2021 | 17577 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 10286 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 6308 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 34025 | 0.010 |
Why?
|